Mercury Computer Systems and NVIDIA Form Strategic Alliance to Address Life Sciences and Geosciences Markets
Combined Technologies To Provide Innovative, Cost-Effective 3D Imaging Solutions
CHELMSFORD, Mass.--November 18, 2004--Mercury Computer Systems, Inc. (NASDAQ: MRCY), announced today its alliance with NVIDIA Corporation (NASDAQ: NVDA) to develop and deliver innovative image processing solutions for the life sciences and geosciences markets. Mercury’s renowned expertise in image and digital signal processing applications and NVIDIA’s leadership in visual computing technology will be combined to create a comprehensive set of solutions to address the growing demands of these imaging applications.
Mercury is leveraging the tremendous performance provided by multiple NVIDIA Quadro® graphics processing units (GPUs) at a reasonable cost to solve the massive and ever-increasing data-intensive challenges present in medical imaging and volumetric visualization and exploration utilizing very large data sets. GPUs are exceptionally efficient at floating-point computation and are becoming increasingly useful for such applications.
“Mercury is breaking new ground in applying NVIDIA Quadro graphics technology to medical imaging,” said Jeff Brown, general manager, professional graphics at NVIDIA. “They have demonstrated increased cost-effectiveness in high-performance 3D imaging solutions by orders of magnitude. We’re pleased to help enable this competence for new and existing customers.”
Mercury and NVIDIA have developed and will be delivering a robust set of offerings based on the NVIDIA Quadro graphics processors, Mercury’s family of imaging software products, and new hardware platforms that leverage the full power of multiple GPUs for imaging applications. The complementary technologies are designed to provide advances in 3D image processing and visualization that reach beyond the current applications of interactive experience in the realm of life sciences, geosciences, biotechnology and simulation.
“Mercury’s alliance with NVIDIA is further evidence of our focus on continuous innovation,” said Marcelo Lima, vice president of Life Sciences, Imaging and Visualization Solutions, Mercury Computer Systems. “Our combined technologies will help to extend current imaging capabilities in new ways and in new applications in our market space.”
Mercury will demonstrate its new life sciences solutions, including the latest acceleration technology, scalable imaging servers, highly optimized software components, and turnkey medical workstation software, in booth #2775 at the annual meeting of the Radiological Society of North America (RSNA), to be held November 28 to December 3 in Chicago, Illinois. Visit www.mc.com/rsna for more information.
For more information on Mercury’s life sciences solutions, contact Mercury or visit lifesciences.mc.com.
NVIDIA Corporation is a worldwide leader in graphics and digital media processors. The Company's products enhance the end-user experience on consumer and professional computing devices. NVIDIA GPUs (graphics processing units), MCPs (media and communications processors), and WMPs (wireless media processors) have broad market reach and are incorporated into a variety of platforms, including consumer and enterprise PCs, notebooks, workstations, PDAs, mobile phones, and video game consoles. NVIDIA is headquartered in Santa Clara, California and employs more than 2,000 people worldwide. For more information, visit the Company’s Web site at www.nvidia.com.
About Mercury Computer Systems, Inc.
Mercury Computer Systems, Inc. (NASDAQ: MRCY) is the leading provider of high-performance embedded, real-time digital signal and image processing solutions. Mercury’s products play a critical role in a wide range of applications, transforming sensor data to information for analysis and interpretation. In military reconnaissance and surveillance platforms the Company’s systems process real-time radar, sonar, and signals intelligence data. Mercury’s systems are also used in state-of-the-art medical diagnostic imaging devices including MRI, CT, PET, and digital X-ray, and in semiconductor imaging applications including photomask generation and wafer inspection. Mercury provides advanced 3D image processing and visualization software and optimized systems to diverse end markets including life sciences, geosciences, and simulation. The Company also provides radio frequency (RF) products for enhanced communications capabilities in military and commercial applications.
Based in Chelmsford, Massachusetts, Mercury serves customers in North America, Europe and Asia through its direct sales force and a network of subsidiaries and distributors. Visit Mercury on the web at www.mc.com.
Forward-Looking Safe Harbor Statement
This press release contains certain forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, including those relating to Mercury’s alliance with NVIDIA and its life sciences products and services. You can identify these statements by our use of the words “may,” “will,” “should,” “plans,” “expects,” “anticipates,” “continue,” “estimate,” “project,” “intend,” and similar expressions. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Such risks and uncertainties include, but are not limited to, general economic and business conditions, economic and technological cycles of the life sciences markets, delays and risks regarding the integration of technologies, competition, changes in technology, delays in completing engineering and manufacturing programs, continued success in technological advances and delivering technological innovations, market acceptance of the Company's products, shortages in components, production delays due to performance quality issues with outsourced components, and changes in applicable health care laws and regulations or the administration of health care programs. These risks and uncertainties also include such additional risk factors as are discussed in the Company's recent filings with the U.S. Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended September 30, 2004. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made.
Certain statements in this press release including, but not limited to, statements as to the benefits, uses, capabilities and performance of NVIDIA Quadro technology by Mercury, plans as to the development and delivery of products by the joint venture and the benefits of 3D imaging solutions designed by Mercury are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Such risks and uncertainties include, but are not limited to, delays in ramping new products into production, unexpected expenses, manufacturing defects, incompatibility of technologies, reliance on third-party manufacturers, general industry trends including cyclical trends in the PC and semiconductor industries, delays in integration of our products, the impact of competitive products and pricing alternatives, changes in industry standards and interfaces, market acceptance of our products, our dependence on third-party developers and publishers and other risks detailed and from time to time in the NVIDIA reports filed with the Securities and Exchange Commission including its Form 10-Q for the quarter ended July 25, 2004. These forward-looking statements speak only as of the date hereof. NVIDIA disclaims any obligation to update these forward-looking statements.
# # #
Mercury Computer Systems, Inc.
Coltrin & Associates
NVIDIA and NVIDIA Quadro are registered trademarks and/or trademarks of NVIDIA Corporation in the United States and other countries. Product and company names mentioned may be trademarks and/or registered trademarks of their respective holders.